Awards
ISPOR 2018 SCIENTIFIC AWARDS WINNERS
The ISPOR Research Presentation Podium and Poster Awards were established in 1998 to recognize the scientific merit of podium and poster presentations of the ISPOR Annual International Meetings, Annual European Congresses, Asia-Pacific and Latin America Conferences.
This year, the ISPOR judges evaluated podium presentations and nominated poster presentations. All podium presentations are considered for an award. Poster presentations in the top 10%, based on abstract review score, are considered and eligible for a poster presentation award.
Evaluations of scientific merit were based upon the following criteria:
- Background provides appropriate perspective / context for the subject
- Objectives / research questions are clearly stated
- Research design / methods / modeling is appropriate and transparent (scores on this will determine winners in case of ties)
- Data sources and/or sampling procedures are clear and appropriate
- Data analyses are appropriate
- Research objectives are met/addressed
- Implications of findings are discussed
- Factual information is kept separate from interpretations or implications
- Abstract is presented in an unbiased manner
- Clarity of presentation
THE RECIPIENTS ARE: . . .
ISPOR Best Podium Research Presentation Awards
Best General Podium Presentations
Ashley Jaska
HT4 - Health Technology Assessment (HTA) Agencies Consideration of Real World Evidence (RWE)
Erin Arthurs
AV3 - Dolutegravir and Rilpivirine to Treat Virologically Suppressed Adults living with HIV-1 : A Canadian Cost Utility Analysis
Lou P. Garrison
VA3 - “It's Tough to Make Predictions, Especially About the Future”: Comparing Life Expectancy Predictions Based on Period Versus Cohort Life Tables
Best Student Podium Research Presentations
Xue Han
CV2 - Secondary Prevention Using Cholesterol-Lowering Medications in Patients Meeting New Treatment Guidelines: A Retrospective Cohort Analysis
Xiaohan Hu
VA2 - Trends in the Economic Value of Newly Approved Cancer Therapies in the U.S.
Franscesco Saverio Mennini
VA4 - Economic Consequences of Anti-HCV Antiviral Treatment Investment From the NHS Perspective
Best New Investigator Podium Research Presentations
Nicolae Done
CV3 - Comparative Effectiveness of Direct Oral anticoagulants Versus Warfarin in Patients with Atrial Fibrillation
J. A. Voelker
HU1 - Annual Change in Controlled Substance Opioid Prescribing and Concomitant Medications from an Urban Academic Emergency Department from 2011- 2016
Christopher G. Fawsitt
AV2 - Cost-Effectiveness analysis of Baseline Testing for Resistance-associated Polymorphisms to Optimize Treatment Duration in Genotype 1 Non-Cirrhotic Treatment-Naive Patients with Chronic Hepatitis C. Virus
ISPOR Best Poster Research Presentation Awards
Best General Poster Research Presentations
Andrzei Orlowski
PUK20 - Comparison of Costs Associated with Turp and Prostatic Urethral Lift for Benign Prostatic Hyperplasia
Ellen R. Thiel
PCV61 - Inpatient Admission Length of Stay and Costs among Vascular Procedure Patients Receiving Perclose Proglide Suture-Mediated Closure Compared to Patients Receiving Surgical Cutdown for Closure of Large Bore Atrerial Access
Peter Classi
PSY107 - Treatment with Prostacyclins Delays and Reduces Hospital Readmissions Among PAH Patients
Best Student Poster Research Presentations
Hrishikesh P. Kale
PCN212 - Economic Burden of Renal Cell Carvcnoma Among Older Adults in the Targeted Therapy Era
Hyeun Ah Kang
PSY63 - Association Between Hydroxyurea Medication Adherence and Vaso-Occlusive Crisis Events Among Texas Medicaid Enrollees with Sickle Cell Disease
Ghadeer Dawwas
PCV20 - Comparative Effectiveness of apixaban Versus Warfarin for the Prevention of Recurrent Venous Thromboembolism and Cardiovascular Diseases in Patients with Venous Thromboembolism
Best New Investigator Poster Research Presentations
Elmor D. Pineda
PMS9 - Predictors and Incidence of Cardiovascular Events in Patients with Rheumatoid Arthritis
Dante M. Grassi
PND8 - Real World Outcomes and Medication Adherence to Disease Modifying Therapies (DMTS) Among Patients with Multiple Sclerosis (MS)
Saurabh P. Nagar
PRS41 - Prescription Opioid Use Among Children and Adolescents with Asthma in the United States: National Estimates from 2011 to 2015
ISPOR would like to thank all the judges who have volunteered their time and efforts during the meeting to score podium and poster research presentations.